Fotivda monotherapy may match or outperform combination therapy in metastatic renal cell carcinoma, offering comparable progression-free survival and objective response rates. The 2025 ASCO Annual ...
A Georgetown University global health and health economics professor encouraged the use of indicators to assess the performance of health systems at a Sept. 3 event. Turbat, who worked as a health ...
Personalized cancer vaccines target tumor-specific neoantigens, potentially improving immune system accuracy in attacking tumors. Zusduri shows promise in treating low-grade, intermediate-risk bladder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results